Big Pharma's Crime Spree: Drug Makers Pushing Products For Unapproved Uses
Pfizer and Lilly lead a parade of U.S. companies that have paid $7 billion in penalties after promoting drugs for uses not approved by the FDA. This u...
Pfizer and Lilly lead a parade of U.S. companies that have paid $7 billion in penalties after promoting drugs for uses not approved by the FDA. This u...
BBC News | Posted 03.28.2008 | Business
US drugmaker Bristol-Myers Squibb says it will cut its 43,000-strong workforce by 10% and close half of its 27 manufacturing plants to save $1.5bn. T...
Wall Street Journal | SCOTT HENSLEY | Posted 03.28.2008 | Business
The Food and Drug Administration is preparing to warn physicians about hazards with drugs used to enhance the diagnosis of heart problems using ultras...
CNNMoney | Posted 03.28.2008 | Business
ImClone Systems Inc. and Bristol-Myers Squibb Co. said Tuesday the drug Erbitux improved the survival rate of lung cancer patients in a late-stage stu...
Bloomberg | David Evans | Posted 11.09.2009 | Business